-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Crohn's disease (CD) is a chronic recurrent gastrointestinal inflammatory disease with unknown pathogenesis.
Crohn's disease (CD) is a chronic recurrent gastrointestinal inflammatory disease with unknown pathogenesis.
Methotrexate (MTX), as an anti-inflammatory drug, was first reported to be used for the treatment of psoriasis, and then it was reported that it could reduce the use of hormones in patients with rheumatoid arthritis.
This study is a retrospective, observational multi-center study.
This study collected data on 110 patients with Crohn's disease who were treated with methotrexate.
This study confirms that monotherapy with methotrexate may be an effective option for patients with Crohn's disease who have previously failed anti-TNFα.
This study confirms that monotherapy with methotrexate may be an effective option for patients with Crohn's disease who have previously failed anti-TNFα.
Original source:
Francisco Mesonero.
wiley.
com/doi/10.
1111/apt.
16315" target="_blank" rel="noopener">Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry.
Leave a message here